Humira pediatrics (Adalimumab)
Brand: Humira pediatrics
Active Ingredient(s): Adalimumab
Strength: 20 mg / 0.2 mL
Pack Size: 2 units Prefilled Syringes
Store in the refrigerator.
DIN: 02474263
Manufacturer: AbbVie Corporation (Canada)
Alternatives:
$1,220.33
*A valid prescription is required for Rx items.
Description
Humira pediatrics (Adalimumab) is an immunosuppressant agent. It is typically used for the treatment of different diseases including treatment of moderately to severely active Crohn’s disease (a type of inflammatory bowel disease) in pediatric patients ≥6 years of age and treatment of moderate-to-severely-active polyarticular juvenile idiopathic arthritis (the most common type of arthritis in kids and teens which causes joint pain and inflammation) for children and adolescents from 2 to 17 years of age who have not responded adequately to other treatments. It may also have other uses.
Additional information
Humira pediatrics (Adalimumab)'s dosage depends on the condition being treated. Your doctor or pharmacist may have suggested a schedule that is more appropriate for your child. It is given by subcutaneous (under the skin) injection, usually in the front of the thigh or abdomen. Important: Follow the instructions on the label. Do not use more of this product, or more often, than prescribed. If you miss a dose, contact your pharmacist. WARNING: Patients receiving adalimumab are at increased risk for serious infections which may result in hospitalization and fatality, infections usually developed in patients receiving concomitant immunosuppressive agents (e.g., methotrexate, corticosteroids). Active tuberculosis (disease caused by bacteria), invasive fungal, bacterial, and viral infections were reported. In addition to its desired action, Humira pediatrics (Adalimumab) may cause some side effects, notably: It may cause skin rash, infections and respiratory infections. It may cause heart problems like high blood pressure and others, stomach pain and bleeding, nausea and vomiting. It may cause bone fractures and muscles pain. Contraindications: Known hypersensitivity or severe allergic reactions to adalimumab or any component of the formulation, severe infection, moderate to severe heart problems. A treatment with Humira pediatrics (Adalimumab) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Humira pediatrics (Adalimumab)
Warning
Each person may react differently to a treatment. If you think this medication may be causing side effects (including those described here, or others), talk to your doctor or pharmacist. He or she can help you to determine whether or not the medication is the source of the problem.
There are no reviews yet.
Reviews